Aventis' Allegra Patent Survives Impax Assault
A federal judge has refused to reconsider a decision to reinstate a patent for allergy drug Allegra in a long-running infringement suit brought by Aventis Pharmaceuticals Inc. and others against Impax...To view the full article, register now.
Already a subscriber? Click here to view full article